Stay updated on Senolytic Therapy in Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Senolytic Therapy in Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Senolytic Therapy in Alzheimer's Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record describes a Phase II randomized, placebo-controlled study of dasatinib and quercetin for older adults with early Alzheimer’s disease or amnestic mild cognitive impairment. It includes the study’s eligibility criteria, treatment schedule, locations, and outcome measures.
    Difference
    53%
    Check dated 2026-11-10T19:36:13.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.2 to v3.8.0, while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T19:53:54.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:27:20.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:46:20.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error instead of the study record content, signaling an access restriction or load failure that prevents viewing the study details.
    Difference
    19%
    Check dated 2026-09-22T22:07:01.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a software/content update to the page. This update does not change the reported study details, eligibility criteria, or other user-facing information.
    Difference
    0.1%
    Check dated 2026-09-15T20:25:22.000Z thumbnail image

Stay in the know with updates to Senolytic Therapy in Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Senolytic Therapy in Alzheimer's Clinical Trial page.